Table 3 Functional response at 4 months stratified for VA response after 2 months.

From: GRAding of functional and anatomical response to DExamethasone implant in patients with Diabetic Macular Edema: GRADE-DME Study

VA response 2 months after DEX-I

VA response 4 months after DEX-I (VA change from baseline), n (%)

Very good (≥ + 10 letters)

Good (+ 5–9 letters)

No change (± 4 letters)

Significant loss (≤ -5 letters)

Naïve eyes, n = 175

Very good FR (≥ + 10 letters), n = 98

80 (81.6)

13 (13.3)

2 (2.0)

3 (3.1)

Good FR (+ 5–9 letters), n = 45

15 (33.3)

24 (53.3)

2 (4.4)

4 (8.9)

No FR (± 4 letters), n = 22

4 (18.2)

10 (45.5)

7 (31.8)

1 (4.5)

Significant VA loss (≤ -5 letters), n = 10

0 (0)

1 (10.0)

3 (30.0)

6 (60.0)

Non-naïve eyes, n = 242

Very good FR (≥ + 10 letters), n = 80

52 (65.0)

16 (20.0)

8 (10.0)

4 (5.0)

Good FR (+ 5–9 letters), n = 44

9 (20.5)

15 (34.1)

11 (25.0)

9 (20.5)

No FR (± 4 letters), n = 79

5 (6.3)

8 (10.1)

50 (63.3)

16 (20.3)

Significant loss (≤ -5 letters), n = 39

1 (2.6)

7 (17.9)

9 (23.1)

22 (56.4)

  1. DEX-I—Dexamethasone implant, FR—Functional response, VA—Visual acuity.